Doxorubicin-peptide conjugates overcome multidrug resistance

M. Mazel; P. Clair; C. Rousselle; P. Vidal; J. M. Scherrmann; D. Mathieu; J. Temsamani

doi:10.1097/00001813-200102000-00003

Back

Doxorubicin-peptide conjugates overcome multidrug resistance

Journal article

Peer reviewed

Doxorubicin-peptide conjugates overcome multidrug resistance

M. Mazel, P. Clair, C. Rousselle, P. Vidal, J. M. Scherrmann, D. Mathieu and J. Temsamani

Anti-Cancer Drugs, Vol.12(2), pp.107--116

2001

DOI: https://doi.org/10.1097/00001813-200102000-00003

PMID: 11261883

Abstract

blood-brain barrier doxorubicin multidrug resistance peptide vector blood-brain-barrier cells in-vitro p-glycoprotein tumor-cells cyclosporine-a k562 cells vincristine resistance drug-delivery adriamycin cancer

Files and links (1)

url

Find in HALView

Metrics

1 Record Views

Details

Title: Doxorubicin-peptide conjugates overcome multidrug resistance
Creators - without role: M. Mazel
P. Clair
C. Rousselle - Inserm
P. Vidal
J. M. Scherrmann - Hôpital Fernand-Widal
D. Mathieu - Université de Montpellier, Institut de Génétique Moléculaire de Montpellier - IGMM
J. Temsamani
Publication Details: Anti-Cancer Drugs, Vol.12(2), pp.107--116
Identifiers: 9935299509311
Academic Unit: Institut de Génétique Moléculaire de Montpellier - IGMM
Language: English
Resource Type: Journal article
Local Fields: hal-02197462